Discover Insights on our Deep Tech Commercialisation Blog

The global biopharmaceutical industry is transforming healthcare at an unprecedented pace. From monoclonal antibodies and biosimilars to mRNA vaccines, gene therapy and personalised medicine, biologics are changing how diseases are prevented, diagnosed and treated. As governments, investors, manufacturers and research organisations seek to strengthen their life sciences sectors, one question has become increasingly important